TAG ARCHIVES FOR OHRP

22
Sep2015

Guest Post: Minimal Risk and Minimal Experience: Can Researchers Competently Navigate OHRP’s New Risk Categories?

Tags:
22 Sep
Comments: 1

The much-anticipated Notice of Proposed Rulemaking—offering the first changes to the Common Rule since its publication in 1991—has now been released. in the interest of providing PRIM&R’s community with as much exposure to the issues raised within it, and the writing and scholarship around the proposed rules changes, PRIM&R and other organizations are cross-posting their thoughts.  This post, from Dr. Celia B. Fisher at Fordham University, focuses on the proposed changes to minimal risk.  It originally appeared on Ethics & Society, the Fordham University Center for Ethics Education blog.

Read more

4
Jun2015

Legislation Changes the Rules for Research Uses of Newborn Dried Bloodspots

Tags:
4 Jun
No comments

By Avery Avrakotos, education and policy manager

In March, the Newborn Screening Saves Live Reauthorization Act of 2014 went into effect. The act, which is an extension of the Newborn Screening Saves Lives Act of 2008, reauthorizes nearly $20 million in funding and expands state-based infant screening programs. It also contains a controversial amendment that requires informed consent for any federally funded research activities using newborn dried bloodspots.
Infant screening programs have been in place in the United States for more than 50 years. The programs, which are Read more

22
Jan2015

PRIM&R’s Response to OHRP’s Draft Guidance on Research Evaluating Standards of Care

Tags:
22 Jan
Comments: 1

by Elisa A. Hurley, PhD, Executive Director, and Avery Avrakotos, Education and Policy Manager

Research on the comparative effectiveness of commonly used interventions is becoming increasingly common as clinicians, researchers, and healthcare funders seek to improve the efficiency and effectiveness of health care by developing a strong evidence base about medical interventions. With the growth of such efforts, questions have emerged about how oversight rules and mechanisms for the protection of human subjects should apply to such endeavors. In October, following more than a year of deliberation and public consultation, the Office for Human Research Protections (OHRP) released draft guidance regarding how the [...] Read more

9
Dec2014

OHRP Discusses Draft Guidance on Appropriate Disclosure of Risks in Research about Standards of Care at AER14

Tags:
9 Dec
No comments

In October, the Office for Human Research Protections (OHRP) released a draft guidance document titled “Guidance on Disclosing Reasonably Foreseeable Risks in Research Evaluating Standards of Care.” The draft guidance “discusses whether risks are considered risks of research when one of the purposes of the research is the evaluation or comparison of risks associated with standards of care. It also discusses disclosing certain reasonably foreseeable risks to prospective subjects when seeking their informed consent to participate in such research activities.”

Following up on the release of the draft guidance, PRIM&R held a session at the 2014 Advancing [...] Read more

4
Nov2014

Unpacking OHRP’s Draft Guidance on Research Evaluating Standards of Care

Tags:
4 Nov
No comments

by Elisa A. Hurley, PhD, Executive Director, and Avery Avrakotos, Education and Policy Manager

On Friday, October 24, the Office for Human Research Protections (OHRP) released a draft guidance document titled “Guidance on Disclosing Reasonably Foreseeable Risks in Research Evaluating Standards of Care.” The draft guidance follows more than a year of deliberation and public consultation prompted by the controversy surrounding the Surfactant, Positive Pressure, and Oxygenation Trial (SUPPORT).

SUPPORT was a multisite randomized trial that took place from 2005 to 2009 and sought to determine, in part, the optimal oxygen saturation for extremely premature infants. [...] Read more